Last checked at 
LONDON (Alliance News) - Nutrition company Glanbia PLC, at its capital markets day on Wednesday, laid out new five year targets with total revenue expected to reach EUR5 billion by 2022.
This compares with revenue of EUR3.6 billion posted for 2017.
Average adjusted earnings per share growth, at constant currency, is expected between 5% to 10% over the five years to 2022. Glanbia is targeting an annual return on capital employed between 10% to 13%, and annual operating cash conversion greater than 80% over the same period.
Shares in Glanbia were up 1.0% at EUR14.78 each on Wednesday.